Mutual funds are among the most preferred types of security in the market today. This is because of  the kind of security they hold compared to other types of investment. While stock investing is proving hard with the rising hardships in the economy, it is not uncommon to find people still wanting to invest in mutual funds, However, one is advised not to invest blindly but to have a look at those that are considered to be the best performing investments. The factors to consider in order to identify the best performing investments are many, and looking at them as a combination improves on the chances of going for nothing less than the best option. One of the factors is income in form of dividends or bond interest payment. This is especially so because of the declining value in stocks. Despite the situation, one still needs an  assurance that there will be returns. The other factor to consider while looking for the best performing mutual funds are the likely future trends. Looking at the history of any given type of investment will most likely give you a hint of how the same investment is likely to perform in future. Do not dismiss an investment on the basis of its current performance because the situation is likely to change, either for good or for worse. Long-term performance is the thing to look at. Any stock that has performed favorably over a period of one or two years is one that is not to be ignored. This record however, should not be done only for the previous year, but should be one that has a long standing in the market. Do not chase after those stocks that have just began performing well in the market and do not also go for those that you are not well aware of.

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
  • StumbleUpon
  • Technorati
  • Tipd

Retail Futures – Top 10 Medical Device Technology Report This report identifies the sectors with the industry’s most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market. Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care. IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of $454.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014. ( http://www.bharatbook.com/Market-Research-Reports/Top-10-Medical-Device-Technology.html ) Market estimates and forecast: The report provides in-depth market estimates and forecast for top ten medical device technologies as follows: • Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others) • Drug delivery (needle free injections, transdermal systems, inhalation system, infusion system) • Molecular diagnostics (biosensors, proteomics, nanotechnology, and others) • Mobility aid technologies • Minimal/non-invasive surgery (stents, bariatric surgery, medical robotics and others) • Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips, protein chips) • Non-invasive monitoring (continuous blood glucose monitoring) • Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others) • Bio-implants (neurostimulation and others) • Tele-medicines Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments. What makes our reports unique? • We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5. • Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive. • No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW. • We provide 10% customization – Research shows that more than 40% of the times, clients do not get the specific intelligence they need in multi-client market research reports. We offer 10% customization in our reports at no extra cost. Get the exact market intelligence you require with real value for money. • 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders. • Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
  • StumbleUpon
  • Technorati
  • Tipd

“The Future of Monoclonal Antibodies – Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis”, essentially provides insights on the monoclonal antibodies market potential, actual sales, actual volume and price forecasts till 2015. The report also delves deep into the monoclonal antibodies market potential in various indications such as rheumatoid arthritis and metastatic NSCLC. In addition, the report provides insights into the monoclonal antibodies R&D pipeline and the potential blockbusters. The report also elucidates monoclonal antibodies competitive landscape including benchmarking of leading companies. Finally, key trend analysis on mergers and acquisitions and licensing agreements involving monoclonal antibodies are also provided. ( http://www.bharatbook.com/detail.asp?id=126919&rt=The-Future-of-Monoclonal-Antibodies-Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html )Rapid Uptake of Monoclonal Antibodies Coupled with Expanded Indications are the Key Drivers for the Growth of the Monoclonal Antibodies MarketThe global monoclonal antibodies market was valued at $27.4 billion in 2008, indicating a Compound Annual Growth Rate (CAGR) of 30.8% between 2000 and 2008. The growth in sales is primarily driven by rapid uptake of monoclonal antibodies, expansion of patient base due to the drug approvals received, and no generics for biological therapies. By 2015, due to the expected launch of many new therapies such as Denosumab and Teplizumab, the sales of monoclonal antibodies is expected to reach $67.6 billion, indicating a CAGR of 13.8% between 2008 and 2015. In 2008-09, 193 Monoclonal Antibodies were in Pipeline with a Majority Being Tested for Various Cancer IndicationsIn 2008-09, 193 monoclonal antibodies were under research and development. Approximately, 375 clinical trials are under process for these 193 monoclonal antibodies. Maximum number of clinical trials is being conducted for various cancer indications. In 2008, cancer accounted for 63.2% of the total clinical trials in process on monoclonal antibodies. Autoimmune diseases accounted for 12.5% of the total clinical trials conducted on monoclonal antibodies.High Growth Potential in Diseases Associated with Genetic Mutations such as Oncology, Autoimmune Diseases and Organ TransplantationsThe total market potential for monoclonal antibodies was estimated at $45.9 billion in 2008. Oncology accounted for 53.8% of the total market potential while autoimmune diseases accounted for 37.3%. The rest of the share was accounted by infectious diseases and organ transplantation. Therapeutic applications of monoclonal antibodies are extending to new therapy areas such as CNS disorders and metabolic disorders. Nevertheless, by 2015, oncology and autoimmune diseases will still account for 90% of the monoclonal antibody market.The M&A Landscape of Monoclonal Antibodies Market is Very Attractive Driven by Heavy Funding by Venture Capitalists and Large Pharmaceutical CompaniesThis report identifies that mergers and acquisitions (M&A) and licensing agreements are very active in the monoclonal antibodies market. The monoclonal antibodies market is inundated by heavy venture capitalist funding on SME biotechnology companies developing monoclonal antibodies. In addition, large pharmaceutical companies are acquiring SME biotech companies having promising monoclonal antibodies in late-stage development. In addition, large companies such as Pfizer and Johnson & Johnson are encouraging collaboration agreements, with institutes and small biotech companies, to develop promising monoclonal antibodies. As a result, the total M&A landscape of the monoclonal antibodies market in 2008-09 was valued at approximately $8 billion. 

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=126919&rt=The-Future-of-Monoclonal-Antibodies-Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html OrContact us at :Bharat Book BureauTel: +91 22 27578668Fax: +91 22 27579131Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/3bbharatbook


Article By:

We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
  • StumbleUpon
  • Technorati
  • Tipd